GeneThera Acquires Majority Stake in Applied Genetics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneThera today announced it has acquired a majority ownership of molecular diagnostic firm Applied Genetics for an undisclosed amount.

GeneThera said the deal is part of a broader strategy to begin revenue generation at Applied Genetics, which is based in Monterrey, Mexico and focuses on commercializing tests for Johne's disease in Mexico.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.